Legal Representation
Attorney
Mark J. Liss
USPTO Deadlines
Next Deadline
1268 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230606)
Due Date
June 06, 2029
Grace Period Ends
December 06, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
15 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 6, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jun 6, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Mar 21, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 21, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 1, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 13, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 10, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 9, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 9, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 5, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 5, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 5, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 28, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 13, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 12, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals, namely, hyaluronate acid and modified hyaluronate acid for use as a soft tissue filler for treatment of damaged tissue; specialized medical capsules, namely, self-contained ampules sold filled with pharmaceuticals for use in dispensing the same in the nature of prepackaged hyaluronic acid and derivatives thereof alone, and in combination with other polysaccharide for pharmaceutical purposes in particular starch, cellulose esters, and with and without lidocaine; dermal tissue filler kits comprising hyaluronic acid gel sold in pre-filled syringes for injecting under the skin for use in reducing and eliminating fine skin lines and wrinkles, filling scars, and contouring the lips and face; pharmaceutical preparations, namely, hyaluronic acid and modified hyaluronic acid, and its derivatives and salts, and biological skin tissue for implantation, all sold in pre-filled syringes for eliminating fine skin lines and wrinkles
Class 010
Dermatological implants for medical use consisting of artificial materials in the nature of visco-supplementation substances for filling skin wrinkles and increasing skin volume
Additional Information
Design Mark
The mark consists of the wording "NEURAMIS" in a stylized form with the capital letter "N" in "NEURAMIS" featuring gradational shading.
Color Claim
Color is not claimed as a feature of the mark.
Translation
The wording "NEURAMIS" has no meaning in a foreign language.
Classification
International Classes
005
010